The US Department of Justice's Inspector General is reviewing controversial DEA tactics that allegedly allowed lethal fentanyl shipments to enter communities to build larger criminal cases.
- Inspector General Don Berthiaume has opened a review into the DEA's practice of allowing drugs to "walk".
- Whistleblowers allege that thousands of fentanyl pills were intentionally left unseized in New Mexico.
- The probe examines whether public safety was sacrificed for the sake of larger prosecutions.
The internal watchdog of the US Justice Department has announced a comprehensive review of a highly controversial law enforcement tactic. Under this approach, federal authorities allegedly allowed lethal fentanyl deliveries to reach the streets to build more robust cases against high-level drug traffickers. The review, announced on Monday, aims to determine if the Drug Enforcement Administration (DEA) knowingly permitted these shipments to proceed to avoid jeopardizing larger investigations.
The inquiry centers on the practice of allowing drugs to "walk". Current and former agents have raised alarms, stating that this tactic put public safety at extreme risk and likely breached Justice Department protocols designed to shield communities from fentanyl—a synthetic opioid that the White House previously labeled a "weapon of mass destruction".
Why This Matters
BozokMedia analysis shows a disturbing disconnect between the DEA's public messaging and its operational reality. While the agency aggressively promoted its "One Pill Can Kill" campaign to warn the public about the lethality of fentanyl, it was simultaneously allowing tens of thousands of pills to circulate in cities like Albuquerque. This discrepancy raises profound ethical questions about the cost of a "successful" prosecution.
"Federal authorities effectively poisoned our community to make cases, prioritizing arrest statistics over human lives."
The probe follows a detailed Associated Press (AP) investigation which revealed that between 2023 and 2025, DEA agents in New Mexico monitored but failed to seize significant fentanyl shipments. In one instance, an internal report noted that the agency watched 74,000 fentanyl pills enter a mobile home park in Albuquerque without intervening.
The legal tension has escalated with New Mexico Attorney General Ral Torrez threatening to sue the Justice Department. Torrez claims the federal government has refused to provide essential records and has blocked agents, including whistleblower David Howell, from being interviewed by state authorities. He argues that the state is bearing the brunt of the societal and financial fallout.
Further allegations have emerged from two additional whistleblowers. One claims that 350,000 pills were ignored during a 2024 wiretap investigation, despite opportunities to seize them. Another whistleblower alleged that a courier transporting between 50,000 and 100,000 pills per trip from Phoenix to Albuquerque was monitored but not arrested for months.
| Perspective | DEA Rationale | Whistleblower/Critic Claim |
|---|---|---|
| Strategy | Surveillance for systemic dismantling | Willful inaction endangering lives |
| Priority | High-value target arrests | Immediate community protection |
Frequently Asked Questions
1. What is the "walk" tactic in drug enforcement?
It is a strategy where agents allow smaller drug shipments to reach their destination to track the distribution network and identify the primary suppliers or "kingpins".
2. Who is initiating this review?
The review is being led by Justice Department Inspector General Don Berthiaume, who serves as the department's internal watchdog.
